Covance sells Caprion; Euro pharma group praises EU trial proposal;

 @DamianFierce: CRO Novasep is spending $3.7M to expand its French API plant, looking to produce targeted cancer drugs. More | Follow @DamianFierce

> Covance ($CVD) has sold its stake in Caprion Proteomics to Chicago Growth Partners, Outsourcing-Pharma.com reports. Article

> The European Association of Pharmaceutical Industries and Associations lauded the EU's proposal to liberalize clinical trial regulations around the continent, saying it will create a healthy, competitive medical research environment. Statement

> Quintiles is partnering with Allscripts to use electronic health records to fuel drug development. News

> Parexel International has tabbed Mark Goldberg to be its new president. The former COO takes over for Josef von Rickenbach, who stepped down this month. Item

> German CRO ICRC-Weyer is upgrading its medical coding procedures, a move it says will allow the company to offer versatile research capabilities to its clients. Release

Suggested Articles

WIRB-Copernicus Group’s clinical services division bought out trial consultancy firm Waife & Associates as it looks to boost its management services.

After three full business days in the position, an abrupt about-face has LabCorp Diagnostics’ CEO John Ratliff heading for the exit.

The initiative will see Evotec mine a kidney biobank for new renal therapy targets before the joint venture out-licenses resulting assets to Vifor.